Healthcare provider profile · identity verified

Charalee K Basaldua, M.D.

Family Practice · LAS VEGAS, NV · NPI 1609036086

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	996	333
Amlodipine Besylate	Amlodipine Besylate	590	192
Lisinopril	Lisinopril	486	157
Losartan Potassium	Losartan Potassium	475	156
Gabapentin	Gabapentin	330	126
Omeprazole	Omeprazole	321	121
Levothyroxine Sodium	Levothyroxine Sodium	315	99
Hydrochlorothiazide	Hydrochlorothiazide	248	83
Metformin Hcl	Metformin Hcl	246	86
Metoprolol Succinate	Metoprolol Succinate	225	68
Rosuvastatin Calcium	Rosuvastatin Calcium	222	75
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	190	50
Albuterol Sulfate Hfa	Albuterol Sulfate	186	64
Tamsulosin Hcl	Tamsulosin Hcl	181	64
Furosemide	Furosemide	166	70
Simvastatin	Simvastatin	151	51
Eliquis	Apixaban	150	42
Metformin Hcl Er	Metformin Hcl	139	47
Potassium Chloride	Potassium Chloride	135	50
Meloxicam	Meloxicam	133	53
Duloxetine Hcl	Duloxetine Hcl	129	45
Metoprolol Tartrate	Metoprolol Tartrate	126	44
Ozempic	Semaglutide	118	25
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	111	40
Pantoprazole Sodium	Pantoprazole Sodium	108	42
Sertraline Hcl	Sertraline Hcl	104	40
Montelukast Sodium	Montelukast Sodium	98	32
Carvedilol	Carvedilol	97	35
Clopidogrel	Clopidogrel Bisulfate	93	30
Fluticasone Propionate	Fluticasone Propionate	93	48
Trazodone Hcl	Trazodone Hcl	91	41
Glimepiride	Glimepiride	83	33
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	83	15
Famotidine	Famotidine	81	26
Allopurinol	Allopurinol	79	27
Alendronate Sodium	Alendronate Sodium	78	30
Humalog Kwikpen U-100	Insulin Lispro	78	18
Finasteride	Finasteride	77	26
Tramadol Hcl	Tramadol Hcl	73	21
Spironolactone	Spironolactone	71	24
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	66	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	65	22
Pioglitazone Hcl	Pioglitazone Hcl	63	20
Atenolol	Atenolol	61	18
Pravastatin Sodium	Pravastatin Sodium	56	20
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	52	23
Baclofen	Baclofen	50	23
Ibuprofen	Ibuprofen	49	25
Warfarin Sodium	Warfarin Sodium	48	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	47	suppressed
Tizanidine Hcl	Tizanidine Hcl	47	20
Glipizide	Glipizide	46	15
Hydralazine Hcl	Hydralazine Hcl	45	18
Triamcinolone Acetonide	Triamcinolone Acetonide	44	32
Pregabalin	Pregabalin	43	suppressed
Meclizine Hcl	Meclizine Hcl	42	25
Oxybutynin Chloride Er	Oxybutynin Chloride	41	13
Escitalopram Oxalate	Escitalopram Oxalate	40	16
Zolpidem Tartrate	Zolpidem Tartrate	39	12
Alprazolam	Alprazolam	38	14
Ezetimibe	Ezetimibe	38	12
Symbicort	Budesonide/Formoterol Fumarate	35	suppressed
Glipizide Er	Glipizide	33	11
Fluoxetine Hcl	Fluoxetine Hcl	31	12
Hydroxyzine Hcl	Hydroxyzine Hcl	31	14
Nystatin	Nystatin	31	14
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	31	17
Insulin Lispro Kwikpen U-100	Insulin Lispro	30	11
Irbesartan	Irbesartan	30	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Citalopram Hbr	Citalopram Hydrobromide	29	11
Diclofenac Sodium	Diclofenac Sodium	28	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	26	suppressed
Donepezil Hcl	Donepezil Hcl	26	11
Propranolol Hcl	Propranolol Hcl	26	suppressed
Buspirone Hcl	Buspirone Hcl	25	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	25	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	24	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Ventolin Hfa	Albuterol Sulfate	24	suppressed
Benazepril Hcl	Benazepril Hcl	23	suppressed
Clonidine Hcl	Clonidine Hcl	23	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Naproxen	Naproxen	22	11
Xarelto	Rivaroxaban	22	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	21	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	20	suppressed
Hydrocortisone	Hydrocortisone	20	suppressed
Temazepam	Temazepam	20	suppressed
Fenofibrate	Fenofibrate	19	suppressed
Telmisartan	Telmisartan	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Farxiga	Dapagliflozin Propanediol	18	suppressed
Ketoconazole	Ketoconazole	18	11
Myrbetriq	Mirabegron	18	suppressed
Nifedipine Er	Nifedipine	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Amoxicillin	Amoxicillin	17	16
Cephalexin	Cephalexin	17	14
Prednisone	Prednisone	17	15
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	16
Azithromycin	Azithromycin	15	15
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Torsemide	Torsemide	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Dilt-Xr	Diltiazem Hcl	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Nitroglycerin	Nitroglycerin	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	13	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Clonazepam	Clonazepam	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	12
Humulin N	Insulin Nph Human Isophane	13	suppressed
Jardiance	Empagliflozin	13	suppressed
Lactulose	Lactulose	13	suppressed
Valsartan	Valsartan	13	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Mirtazapine	Mirtazapine	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Colchicine	Colchicine	11	suppressed
Estradiol	Estradiol	11	suppressed
Labetalol Hcl	Labetalol Hcl	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Testosterone Cypionate	Testosterone Cypionate	11	suppressed
Xtampza Er	Oxycodone Myristate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error